Esperion Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 14.83 M | $39.31 M | 0.82% | 7.54% |
| VANGUARD GROUP INC | 11/07/2025 | 12.09 M | $32.04 M | 3.21% | 6.14% |
| TWO SEAS CAPITAL LP | 11/14/2025 | 9.75 M | $25.84 M | -2.06% | 4.95% |
| WASATCH ADVISORS LP | 11/14/2025 | 7.06 M | $18.71 M | -31.71% | 3.59% |
| PENDERFUND CAPITAL MANAGEMENT LTD. | 11/14/2025 | 6.68 M | $17.69 M | 0.00% | 3.39% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 4.75 M | $12.59 M | 3.65% | 2.41% |
| STATE STREET CORP | 11/14/2025 | 4.48 M | $11.87 M | 19.16% | 2.28% |
| MORGAN STANLEY | 11/14/2025 | 4.06 M | $10.75 M | 284.24% | 2.06% |
| NUVEEN, LLC | 11/12/2025 | 3.71 M | $9.83 M | 778.12% | 1.89% |
| AIGH CAPITAL MANAGEMENT LLC | 10/31/2025 | 3.00 M | $7.95 M | 100.00% | 1.52% |
| MARSHALL WACE, LLP | 11/13/2025 | 2.52 M | $6.68 M | -52.54% | 1.28% |
| ROYCE & ASSOCIATES LP | 11/12/2025 | 2.29 M | $6.08 M | 100.00% | 1.17% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 2.24 M | $5.93 M | 22.46% | 1.14% |
| JANE STREET GROUP, LLC | 11/14/2025 | 1.95 M | $5.18 M | 223.47% | 0.99% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 1.91 M | $5.06 M | -8.87% | 0.97% |
| NORTHERN TRUST CORP | 11/14/2025 | 1.85 M | $4.90 M | 3.60% | 0.94% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.71 M | $4.53 M | 113.93% | 0.87% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.53 M | $4.06 M | -34.29% | 0.78% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2025 | 1.50 M | $3.98 M | 100.00% | 0.76% |
| UBS GROUP AG | 11/13/2025 | 1.25 M | $3.30 M | -18.92% | 0.63% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 974.86 K | $2.58 M | 115.37% | 0.50% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 954.45 K | $2.53 M | 14.11% | 0.48% |
| JPMORGAN CHASE & CO | 11/26/2025 | 945.49 K | $2.51 M | 68.42% | 0.48% |
| ROYAL BANK OF CANADA | 11/14/2025 | 909.23 K | $2.41 M | -22.06% | 0.46% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 773.90 K | $2.05 M | 164.67% | 0.39% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 750.00 K | $1.99 M | 100.00% | 0.38% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 681.29 K | $1.81 M | 100.00% | 0.35% |
| INVESCO LTD. | 11/13/2025 | 619.77 K | $1.64 M | 25.48% | 0.31% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 586.42 K | $1.55 M | -4.98% | 0.30% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 463.09 K | $1.23 M | 8.44% | 0.24% |
| VICTORY CAPITAL MANAGEMENT INC | 11/12/2025 | 426.87 K | $1.13 M | 1,739.78% | 0.22% |
| CITADEL ADVISORS LLC | 11/14/2025 | 422.90 K | $1.12 M | 12.83% | 0.21% |
| WOODLINE PARTNERS LP | 11/14/2025 | 382.09 K | $1.01 M | -74.59% | 0.19% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 357.36 K | $947.00 K | 1,483.40% | 0.18% |
| BARCLAYS PLC | 11/12/2025 | 335.61 K | $889.36 K | -7.22% | 0.17% |
| SUMMIT WEALTH GROUP, LLC | 10/23/2025 | 323.00 K | $855.95 K | 0.00% | 0.16% |
| WALLEYE CAPITAL LLC | 11/14/2025 | 319.19 K | $845.86 K | 100.00% | 0.16% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 304.57 K | $807.12 K | -63.58% | 0.15% |
| MARINER, LLC | 11/14/2025 | 302.51 K | $801.66 K | 100.00% | 0.15% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 296.81 K | $786.55 K | 38.45% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 285.50 K | $756.58 K | 24.67% | 0.15% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 284.91 K | $755.00 K | 54.53% | 0.14% |
| RHUMBLINE ADVISERS | 11/06/2025 | 277.49 K | $735.34 K | 0.65% | 0.14% |
| MACKENZIE FINANCIAL CORP | 11/13/2025 | 272.96 K | $723.34 K | 2,232.97% | 0.14% |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 11/14/2025 | 263.28 K | $697.68 K | 234.47% | 0.13% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 256.20 K | $678.93 K | 483.60% | 0.13% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 11/10/2025 | 254.27 K | $673.80 K | 0.00% | 0.13% |
| DIAMETRIC CAPITAL, LP | 11/13/2025 | 236.15 K | $625.78 K | -65.21% | 0.12% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 11/14/2025 | 222.48 K | $589.58 K | 0.00% | 0.11% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 211.76 K | $561.16 K | -24.31% | 0.11% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Esperion Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 273 institutional investors and hedge funds held shares of Esperion Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 14.83 M
VANGUARD GROUP INC: 12.09 M
Two Seas Capital LP: 9.75 M
WASATCH ADVISORS LP: 7.06 M
PenderFund Capital Management Ltd.: 6.68 M
GEODE CAPITAL MANAGEMENT, LLC: 4.75 M
54.87% of Esperion Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 135.13 M shares in the last 24 months. This purchase volume represents approximately $445.94 M in transactions.